Global Digital Pathology Market worth USD 980.65 Million by 2024

Global Digital Pathology Market worth USD 980.65 Million by 2024

Pune, India, May 01, 2018 -- /360iResearch/ -- The report "Global Digital Pathology Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2018 Update)", published by 360iResearch, states that the global market was valued at USD 360.53 million in 2016 and is projected to reach USD 980.65 million by 2024, growing at a CAGR of 13.32% from 2016 to 2024.

The major forces driving the growth of the digital pathology market include the quality improvement in service delivery and increasing prevalence of chronic disease. Moreover, technological advancement in healthcare is also one of the factors that is driving the market growth. However certain factors such as the high cost system and lack of standards may hinder the market growth. In the middle of difficulty lies opportunity such as the streamline drug development processes in discovery, pre-clinical and clinical trials, evolving technologies improve the pathologist’s workstation experience, and increasing use in education, research, and training. The possible challenges for the market growth are legal barriers and cultural resistance, and data management and storage challenges. But key players in the market are overcoming the challenges with continual improvement and innovation.

Based on end user, the global digital pathology market is studied across Academic & Research Institutes, Infectious Diseases, Laboratories, and Pharmaceutical & Biotechnology Companies. Based on deployment, the global digital pathology market is studied across On-Cloud, and On-Premises. Based on geography, the global digital pathology market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.

The report features a competitive scenario of the digital pathology market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are 3DHISTECH Ltd, Corista LLC, DeepBio, Inc., Definiens, Inc., Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Inspirata, Inc., Leica Biosystems Nussloch Gmbh, OptraSCAN, Inc., Philips Healthcare, Proscia, Inc., Sectra AB, Ventana Medical Systems, Inc., and Visiopharm.

About 360iResearch

360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.

Miss. Shikha Sachan
Business Lead,
Nyati Elan,
Wagholi, Pune,
India - 412207.
USA: +1-530-264-8485
India: +91-9075017818
Email: [email protected]